Cited 0 times in Scipus Cited Count

Effect of gonadotropin-releasing hormone agonist monotherapy and combination therapy with growth hormone on final adult height in girls with central precocious puberty

DC Field Value Language
dc.contributor.authorCho, AY-
dc.contributor.authorShim, YS-
dc.contributor.authorLee, HS-
dc.contributor.authorHwang, JS-
dc.date.accessioned2023-05-04T06:41:40Z-
dc.date.available2023-05-04T06:41:40Z-
dc.date.issued2023-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/25294-
dc.description.abstractThis study aimed to compare clinical parameters, including final adult height (FAH), in girls with central precocious puberty treated with gonadotropin-releasing hormone agonists (GnRHa) with and without growth hormone (GH). This retrospective study reviewed data of 210 girls with precocious puberty who had reached FAH in a long-term trial of GnRHa treatment. The subjects were divided into the GnRHa treatment group (n = 188), and the combined GnRHa + GH treatment group (n = 22). Chronological age, bone age, height, height standard deviation score, predicted adult height (PAH), FAH, Tanner stage, and hormone levels were assessed during the treatment period. At the start of treatment, PAH was 156.35 ± 6.34 cm in the GnRHa monotherapy group and 150.41 ± 5.32 cm in the GnRHa + GH group (P < 0.001). At the end of treatment, PAH was 166.25 ± 5.26 cm in the GnRHa group and 164.07 ± 4.99 cm in the combined GnRHa + GH treatment group, which had increased compared to the start of treatment. The FAH in the GnRHa group and GnRHa + GH combination group were 161.07 ± 4.78 cm and 159.63 ± 3.8 6 cm, respectively, without significant difference. In addition, the height gain (FAH–PAH) was significantly higher in the GnRHa + GH group than the GnRHa group (9.22 ± 6.03 cm vs. 4.72 ± 5.01 cm, P < 0.001). In girls with central precocious puberty, the height gain in the FAH compared to PAH at the start of treatment was significantly higher with the GnRHa + GH combination treatment.-
dc.language.isoen-
dc.subject.MESHAdult-
dc.subject.MESHBody Height-
dc.subject.MESHFemale-
dc.subject.MESHGonadotropin-Releasing Hormone-
dc.subject.MESHGrowth Hormone-
dc.subject.MESHHuman Growth Hormone-
dc.subject.MESHHumans-
dc.subject.MESHPuberty, Precocious-
dc.subject.MESHRetrospective Studies-
dc.titleEffect of gonadotropin-releasing hormone agonist monotherapy and combination therapy with growth hormone on final adult height in girls with central precocious puberty-
dc.typeArticle-
dc.identifier.pmid36690835-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870989-
dc.contributor.affiliatedAuthorShim, YS-
dc.contributor.affiliatedAuthorLee, HS-
dc.contributor.affiliatedAuthorHwang, JS-
dc.type.localJournal Papers-
dc.identifier.doi10.1038/s41598-023-28602-3-
dc.citation.titleScientific reports-
dc.citation.volume13-
dc.citation.number1-
dc.citation.date2023-
dc.citation.startPage1264-
dc.citation.endPage1264-
dc.identifier.bibliographicCitationScientific reports, 13(1). : 1264-1264, 2023-
dc.identifier.eissn2045-2322-
dc.relation.journalidJ020452322-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Pediatrics & Adolescent Medicine
Files in This Item:
36690835.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse